Daklana 60mg Tablet

Daklana 60mg Tablet contains the active ingredient Daclatasvir Dihydrochloride. It is a potent antiviral medication used in the treatment of chronic hepatitis C virus (HCV) infection. Daclatasvir Dihydrochloride is a direct-acting antiviral agent that inhibits the action of the NS5A protein, essential for HCV replication. By blocking viral replication, Daklana 60mg Tablet helps to reduce HCV viral load, improve liver function, and prevent the progression of liver disease.

Uses:

1. Chronic Hepatitis C Virus (HCV) Infection: Daklana 60mg Tablet is indicated for the treatment of chronic HCV infection in adults. It is effective against multiple genotypes of HCV and is often used in combination with other antiviral medications, such as Sofosbuvir or Ribavirin, to achieve sustained virologic response (SVR) and cure the infection.

Side Effects:

While Daklana 60mg Tablet is generally well-tolerated, it may cause side effects in some individuals. Common side effects associated with Daclatasvir Dihydrochloride include:

• Headache: Headaches are a frequently reported side effect during treatment with Daklana 60mg Tablet. Over-the-counter pain relievers may help alleviate headache symptoms.
• Fatigue: Fatigue or weakness may occur during treatment with Daclatasvir Dihydrochloride. Getting adequate rest and maintaining a healthy lifestyle can help manage fatigue.
• Nausea: Some patients may experience nausea while taking Daklana 60mg Tablet. Eating small, frequent meals and avoiding spicy or greasy foods may help reduce nausea.
• Insomnia: Difficulty sleeping or insomnia may occur in some individuals. Establishing a regular sleep schedule and practicing relaxation techniques may improve sleep quality.

Precautions:

• Pregnancy and Breastfeeding: Daklana 60mg Tablet should not be used during pregnancy due to the risk of fetal harm. Women of childbearing potential should use effective contraception during treatment and for a period after discontinuation of therapy. The safety of Daclatasvir Dihydrochloride during breastfeeding is unknown.
• Renal Dysfunction: Patients with pre-existing renal impairment should use Daklana 60mg Tablet with caution, as dosage adjustments may be necessary. Regular monitoring of renal function is recommended during treatment.
• Liver Dysfunction: Patients with severe liver impairment should use Daclatasvir Dihydrochloride cautiously, as dosage adjustments may be necessary. Close monitoring of liver function is recommended during treatment.